Source: International Congress 2015 – Inflammation and remodelling in lung disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Rasoul Aliannejad (Tehran, Islamic Republic of Iran), B. Fatemeh Nobakht M. Gh., Rasoul Aliannejad, Salman Taheri, Mostafa Rezaei-Tavirani, Fariba Fathi, Afsaneh Arefi Oskouie. Serum metabolomic analysis of mustard airway diseases by nuclear magnetic resonance spectrometry: A pilot study. Eur Respir J 2015; 46: Suppl. 59, 3925

Member's Comments

No comment yet.

Related content which might interest you: Metabolic profiling detects biomarkers of protein degradation in COPD patients Source: Eur Respir J 2012; 40: 345-355 Year: 2012 Metabonomic analysis of exhaled breath condensate in adults by nuclear magnetic resonance spectroscopy Source: Eur Respir J 2008; 32: 1175-1183 Year: 2008 A liquid chromatography MS/MS metabolomics study of COPD patients Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015 Metabonomic approach for noninvasive diagnosis of inflammatory lung diseases through nuclear magnetic resonance analysis of exhaled breath condensate Source: Annual Congress 2007 - Novel therapeutic targets and disease markers in pulmonary pathology Year: 2007 Value of proton magnetic resonance spectroscopy of brain to study the cerebral metabolic abnormalities in COPD: Initial experience Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation Year: 2013 NMR serum metabolomics for understanding the pathophysiology of COPD associated PH: A pilot study Source: International Congress 2018 – Pathobiology of pulmonary hypertension Year: 2018 Metabolomic analysis by nuclear magnetic resonance spectroscopy of exhaled breath condensate in patients with cystic fibrosis Source: Annual Congress 2009 - Cystic fibrosis: understanding a complex disease Year: 2009 Metabolomic signatures in nuclear magnetic resonance spectra of exhaled breath condensate identify asthma Source: Eur Respir J 2012; 39: 500-502 Year: 2012 Evaluation of parametric response mapping for monitoring COPD subtypes Source: International Congress 2014 – COPD and PAH related imaging Year: 2014 A metabonomic approach to prognostic evaluation of ALI by high-resolution nuclear magnetic resonance (HR NMR) spectroscopy Source: Annual Congress 2011 - Acute respiratory failure Year: 2011 Metabonomic analysis of EBC in adults by nuclear magnetic resonance spectroscopy Source: Annual Congress 2008 - New frontiers in noninvasive assessment of the lungs Year: 2008 Nuclear magnetic resonance and mass spectrometry analysis of exhaled breath condensate Source: Annual Congress 2009 - Noninvasive monitoring of airway inflammation: beyond exhaled nitric oxide Year: 2009 Altered serum metabolomics in COPD: analysis of the SPIROMICS cohort Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond Year: 2018 Mass spectrometry proteomic biomarkers identify acute COPD exacerbations Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity Year: 2020 The analysis of breath air by laser spectroscopy method for diagnosis of COPD Source: International Congress 2014 – Airway biomarkers Year: 2014 Breath analysis in real time by mass spectrometry in chronic obstructive pulmonary disease Source: Annual Congress 2013 –Expiration, exhalation and exhaustion: measures of dynamic volumes, breath analysis and respiratory muscles Year: 2013 LATE-BREAKING ABSTRACT: Exploiting the ability of 1H-NMR to differentiate patients with severe alpha-1-antitrypsin deficiency from controls based on metabolome profiling of exhaled breath condensate Source: International Congress 2016 – Late-breaking topics in airways disease Year: 2016 Metabolomic signature in COPD. Plasma and lung tissue comparison identify sphingolipids as potential biomakers Source: International Congress 2014 – Markers Year: 2014 Ion mobility spectrometry – a new method in the diagnostic approach to sarcoidosis? Preliminary data Source: Annual Congress 2006 - Clinical features and disease markers of sarcoidosis Year: 2006